Therapeutic monitoring of drugs is highly useful in individualizing treatment. Imatinib is a chemotherapeutic used in the treatment of chronic myeloid leukemia (CML). Therapeutic monitoring of imatinib and its metabolites results in better clinical outcomes for the patient. However, imatinib metabolization has been poorly studied. With this in mind, Friedecky et al. (2015) used high-resolution mass spectrometry Read the rest of this article
The post Detailed Imatinib Metabolite Study in Chronic Myeloid Leukemia appeared first on Accelerating Science.
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1OFGLBH
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου